Tag: Death and dying

Infusion pump problems prompt early FDA safety warning

Editor's Note Risk of delayed therapy and death related to Ivenix large-volume infusion pumps is prompting supplier Fresenius Kabi USA to pull a subset of the devices from the market, according to an early alert from The US Food and Drug Administration (FDA). Issued December 11, the early alert is…

Read More

By: Matt Danford
December 12, 2024
Share

FDA designates Class 1 recall for insulin syringes

Editor's Note The US Food and Drug Administration (FDA) designated Cardinal health’s recall of certain lots of the Monoject U-100 1 mL Syringe Luer-Lock with Tip Cap Soft Pack a Class 1, the most severe recall category indicating serious risk of injury or death. The product is designed to administer…

Read More

By: Matt Danford
December 5, 2024
Share

FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators

Editor's Note The US Food and Drug Administration (FDA) has designated Class 1 recalls—the most severe category indicating risk of serious injury or death—involving three systems: Atlan anesthesia workstations from Draeger, CADD-Solis ambulatory infusion pumps from Smiths Medical, and Trilogy Evo ventilators from Philips Respironics. FDA issued all three announcements…

Read More

By: Matt Danford
November 20, 2024
Share

Study finds high rates of preventable, adverse events in perioperative care

Editor's Note Adverse events (AEs) remain widespread in perioperative care, affecting nearly one in three patients and resulting in substantial and often preventable patient harm, according to a retrospective cohort study published November 13 in The BMJ. The study analyzed 1,009 weighted admissions from a sample of 64,121 surgical patients…

Read More

By: Matt Danford
November 19, 2024
Share

Out-of-hospital cardiac arrest survival rates lag pre-pandemic levels, racial disparities persist

Editor's Note Survival rates following out-of-hospital cardiac arrest (OHCA) have not returned to pre-pandemic levels and continue to reflect racial disparities, according to a preliminary study set for presentation at the American Heart Association’s Scientific Sessions 2024. Analyzing data from over half a million U.S. adults who experienced OHCA between…

Read More

By: Matt Danford
November 14, 2024
Share

Study: Beta-blockers could increase postoperative stroke risk

Editor's Note Research presented at the American Society of Anesthesiologists (ASA) annual meeting has found that beta-blocker use is associated with an increased risk of postoperative stroke, particularly among Black and Hispanic patients undergoing noncardiac surgeries, Medpage Today reported October 20. According to the article, the retrospective study analyzed the…

Read More

By: Matt Danford
November 7, 2024
Share

Study: Repeated fasting for multiple surgeries risks malnutrition, mortality

Editor's Note Research shows repeated fasting for multiple surgeries during a single hospital stay significantly raises the risk of protein-calorie malnutrition, leading to longer recovery times, increased healthcare costs, and a higher likelihood of death. HealthDay covered the news October 21. Presented at the American Society of Anesthesiologists annual meeting,…

Read More

By: Matt Danford
October 24, 2024
Share

Cardiovascular disease trends raise alarms on primary care

Editor's Note In a series of interviews with STAT, 11 cardiologists and other clinicians, including the FDA commissioner, said a crisis in primary care is dragging back progress in the nation’s cardiovascular health. Published October 15, the article begins with commentary on a stark warning from the American Heart Association…

Read More

By: Matt Danford
October 17, 2024
Share

FDA designates Class 1 recall for IPV therapy system

Editor's Note The US Food and Drug Administration (FDA) has deemed the recall of Sentec Percussionaire’s Phasitron 5 In-Line Valve—a component of the manufacturer’s Intrapulmonary Percussive Ventilation (IPV) therapy system—a Class 1, the most severe category indicating serious risk of injury or death.   According to the agency’s October 2…

Read More

By: Matt Danford
October 3, 2024
Share

FDA designates Class 1 recalls for infusion pump software, ventilator software

Editor's Note The US Food and Drug Administration (FDA) designated software-related recalls for Fresenius Kabi USA’s Iveni Infusion Systems and Philips Respironics Triology Evo ventilators as class 1, the most severe category indicating serious risk of injury or death. According to FDA’s October 1 announcement, Fresenius recalled the Ivenix Infusion…

Read More

By: Matt Danford
October 2, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat